79.96
0.55 (0.69%)
| 前收盘价格 | 79.41 |
| 收盘价格 | 79.33 |
| 成交量 | 322,076 |
| 平均成交量 (3个月) | 559,403 |
| 市值 | 4,015,902,976 |
| 市盈率 (P/E TTM) | 33.18 |
| 预期市盈率 (P/E Forward) | 14.88 |
| 价格/销量 (P/S) | 2.90 |
| 股市价格/股市净资产 (P/B) | 4.38 |
| 52周波幅 | |
| 利润日期 | 6 Feb 2025 |
| 营业毛利率 | 9.10% |
| 营业利益率 (TTM) | 16.44% |
| 稀释每股收益 (EPS TTM) | 2.41 |
| 季度收入增长率 (YOY) | 8.60% |
| 季度盈利增长率 (YOY) | 35.80% |
| 总债务/股东权益 (D/E MRQ) | 149.62% |
| 流动比率 (MRQ) | 3.49 |
| 营业现金流 (OCF TTM) | 84.94 M |
| 杠杆自由现金流 (LFCF TTM) | 85.98 M |
| 资产报酬率 (ROA TTM) | 5.88% |
| 股东权益报酬率 (ROE TTM) | 13.97% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看涨 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
| 股票 | Haemonetics Corporation | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | -4.0 |
| 平均 | -0.50 |
|
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Core |
| 内部持股比例 | 0.89% |
| 机构持股比例 | 113.64% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Neuberger Berman Group Llc | 30 Sep 2024 | 4,027,103 |
| Thrivent Financial For Lutherans | 30 Sep 2024 | 1,100,183 |
| Schroder Investment Management Group | 30 Sep 2024 | 937,289 |
| Westfield Capital Management Co Lp | 30 Sep 2024 | 823,663 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 120.00 (Raymond James, 50.08%) | 购买 |
| 中 | 114.00 (42.57%) | |
| 低 | 108.00 (Barrington Research, 35.07%) | 购买 |
| 平均值 | 114.00 (42.57%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 84.35 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JP Morgan | 06 Dec 2024 | 116.00 (45.07%) | 购买 | 81.19 |
| Barrington Research | 04 Dec 2024 | 108.00 (35.07%) | 购买 | 83.51 |
| 08 Nov 2024 | 108.00 (35.07%) | 购买 | 87.42 | |
| Needham | 03 Dec 2024 | 112.00 (40.07%) | 购买 | 85.26 |
| 15 Nov 2024 | 112.00 (40.07%) | 购买 | 89.22 | |
| Raymond James | 08 Nov 2024 | 120.00 (50.08%) | 购买 | 87.42 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合